| |
| |
|
| Insider
Information: |
Stampacchia Otello |
| Relationship: |
Director |
| City: |
George Town, Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
17,297,599 |
|
|
Indirect Shares
|
21,254,784 |
|
|
| Direct
Value |
$89,623,010 |
|
|
|
Indirect Value
|
$117,310,442 |
|
|
| Total
Shares |
38,552,383 |
|
|
| Total
Value |
$206,933,453 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 78.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gossamer Bio Inc |
GOSS |
Former director., 10% ... |
2019-09-18 |
6,737,023 |
2019-02-12 |
6,953,416 |
Premium* |
|
|
Morphic Holding, Inc. |
MORF |
Director |
2021-04-30 |
2,068,913 |
2019-07-01 |
2,969,582 |
Premium* |
|
|
Replimune Group Inc |
REPL |
10% Owner |
2022-03-16 |
4,673,380 |
2022-03-14 |
4,763,380 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
3,818,283 |
2020-10-14 |
3,818,283 |
Premium* |
|
|
Omega Alpha Spac |
OMEG |
Chief Executive Office... |
|
0 |
2021-01-11 |
501,000 |
Premium* |
|
|
Ikena Oncology, Inc. |
IKNA |
Director |
2021-03-30 |
0 |
2021-03-30 |
2,249,123 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRON |
Kronos Bio, Inc. |
Director |
– • • |
2020-10-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,451 |
|
- |
|
| KRON |
Kronos Bio, Inc. |
Director |
– • • |
2020-10-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
19,451 |
|
- |
|
| OMEG |
Omega Alpha Spac |
Chief Executive OfficerOfficer |
• • • |
2021-01-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,735,000 |
|
- |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2021-11-10 |
4 |
AS |
$33.50 |
$369 |
D/D |
(11) |
4,853,694 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2021-11-16 |
4 |
AS |
$33.50 |
$5,126 |
D/D |
(153) |
4,811,245 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-01-21 |
4 |
AS |
$29.98 |
$7,915 |
D/D |
(264) |
2,810,475 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2021-01-15 |
4 |
AS |
$45.19 |
$86,584 |
D/D |
(1,916) |
5,325,391 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-02-12 |
4 |
AS |
$37.47 |
$89,153 |
D/D |
(2,364) |
2,631,132 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2021-11-18 |
4 |
AS |
$33.50 |
$81,774 |
D/D |
(2,441) |
4,808,804 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2020-12-24 |
4 |
AS |
$32.48 |
$94,220 |
D/D |
(2,883) |
2,965,807 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-02-24 |
4 |
AS |
$34.27 |
$104,249 |
D/D |
(2,998) |
2,587,544 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-28 |
4 |
AS |
$55.36 |
$187,536 |
D/D |
(3,366) |
2,086,071 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-01-11 |
4 |
AS |
$30.15 |
$101,967 |
D/D |
(3,382) |
2,864,005 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2021-11-08 |
4 |
AS |
$33.53 |
$127,984 |
D/D |
(3,817) |
4,861,242 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-02-11 |
4 |
AS |
$37.76 |
$151,234 |
D/D |
(4,005) |
2,633,496 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-02-19 |
4 |
AS |
$34.82 |
$157,801 |
D/D |
(4,436) |
2,604,515 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-04-26 |
4 |
AS |
$55.54 |
$290,993 |
D/D |
(5,146) |
2,096,775 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • • |
2021-02-08 |
4 |
AS |
$45.00 |
$236,205 |
D/D |
(5,249) |
5,141,321 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-02-09 |
4 |
AS |
$39.76 |
$217,830 |
D/D |
(5,461) |
2,643,569 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • • |
2021-09-16 |
4 |
AS |
$32.55 |
$180,229 |
D/D |
(5,537) |
5,002,708 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-01-12 |
4 |
AS |
$30.10 |
$173,316 |
D/D |
(5,758) |
2,858,247 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Director |
– • – |
2021-11-05 |
4 |
AS |
$33.50 |
$193,965 |
D/D |
(5,790) |
4,865,059 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-02-05 |
4 |
AS |
$37.78 |
$222,275 |
D/D |
(5,881) |
2,673,902 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-02-16 |
4 |
AS |
$36.42 |
$220,395 |
D/D |
(6,025) |
2,625,107 |
0 |
% |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-02-10 |
4 |
AS |
$37.34 |
$227,782 |
D/D |
(6,068) |
2,637,501 |
0 |
% |
|
119 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
